Format

Send to

Choose Destination
Pak J Med Sci. 2019 Jan-Feb;35(1):177-182. doi: 10.12669/pjms.35.1.431.

Effects of lymph node metastasis of thoracic esophageal squamous cell carcinoma on design of radiotherapy target volume.

Author information

1
Guobing Pan, Department of Medical Engineering, The 476th Hospital of PLA, Fuzhou 350002, Fujian Province, P. R. China.
2
Haitao Pan, Department of Radiology, The 476th Hospital of PLA, Fuzhou 350002, Fujian Province, P. R. China.
3
Yuang Zhang, Department of Radiotherapy, The 476th Hospital of PLA, Fuzhou 350002, Fujian Province, P. R. China.
4
Haitao Shuai, Department of Radiology, The 476th Hospital of PLA, Fuzhou 350002, Fujian Province, P. R. China.

Abstract

Objective:

To analyze the correlation between lymph node metastasis of thoracic esophageal squamous cell carcinoma (ESCC) and clinical and pathological factors, and to provide a reference for the outline of clinical target volume.

Methods:

The pathological characteristics of 1034 thoracic ESCC patients after surgery were described, and the correlations between clinical and pathological factors and lymph node metastasis were studied by univariate and Logistic multivariate analyses.

Results:

Lymph node metastasis was significantly correlated with tumor length, invasion depth and differentiation degree (P<0.01), but not gender, age, tumor site or pathological type (P>0.05). Logistic multivariate analysis showed that tumor length, invasion depth and differentiation degree were independent risk factors for thoracic ESCC. The lymph node metastasis rates of mid-thoracic ESCC in the middle mediastinum, lower-thoracic ESCC in the lower mediastinum and abdominal cavity were 18.5%, 35.3% and 19.7% respectively in the T1-T2 stage. In the T3-T4 stage, the lymph node metastasis rates of mid-thoracic ESCC in the middle mediastinum and abdominal cavity were 39.6% and 17.4% respectively, and those of lower-thoracic ESCC in middle and lower mediastina and abdominal cavity were 21.1%, 43.4% and 29.8% respectively. Highly/moderately differentiated mid-thoracic ESCC in the middle mediastinum, lower-thoracic ESCC in middle and lower mediastina and abdominal cavity had the lymph node metastasis rates of 34.7%, 15.1%, 33.5% and 23.7% respectively. Lowly differentiated mid-thoracic ESCC in the middle mediastinum and abdominal cavity had the lymph node metastasis rates of 46.9% a 29.6% respectively, and those of lower-thoracic ESCC in middle and lower mediastina and abdominal cavity were 25.5%, 49.1% and 27.3% respectively.

Conclusion:

During the outline of radiotherapy target volume for thoracic ESCC, tumor length, invasion depth and differentiation degree should be comprehensively considered to selectively irradiate the regions prone to lymph node metastasis.

KEYWORDS:

Esophageal squamous cell carcinoma; Lymph node metastasis; Radiotherapy

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center